|
[1]
|
Deng, X., Ma, J., Song, M., et al. (2019) Effects of Products Designed to Modulate the Gut Microbiota on Hyperlipi-daemia. European Journal of Nutrition, 58, 2713-2729. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
唐佳丽, 冯小乐, 郭斌, 等. circRNA在动脉粥样硬化中的相关研究进展[J]. 牡丹江医学院学报, 2023, 44(4): 134-137.
|
|
[3]
|
Ma, L.Y., Chen, W.W., Gao, R.L., Liu, L.S., Zhu, M.L., Wang, Y.J., Wu, Z.S., Li, H.J., Gu, D.F., Yang, Y.J., Zheng, Z. and Hu, S.S. (2020) China Cardiovascular Diseases Report 2018: An Updated Summary. Journal of Geriatric Cardiology, 17, 1-8.
|
|
[4]
|
Maguire, E.M., Pearce, S.W.A. and Xiao, Q. (2019) Foam Cell Formation: A New Target for Fighting Atherosclerosis and Cardiovascular Disease. Vascular Pharmacology, 112, 54-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Karr, S. (2017) Epidemiology and Management of Hyperlipidemia. The American Journal of Managed Care, 23, S139-S148.
|
|
[6]
|
赵成, 谭树华. 高胆固醇血症治疗药物研究进展[J]. 科学技术创新, 2018(10): 52-53.
|
|
[7]
|
Wang, C., Niimi, M., Watanabe, T., et al. (2018) Treatment of Atherosclerosis by Traditional Chinese Medicine: Questions and Quandaries. Atherosclerosis, 277, 136-144. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Li, T.T., Wang, Z.B., Li, Y., et al. (2019) The Mecha-nisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Atherosclerosis. Chinese Journal of Natural Medicines, 17, 401-412. [Google Scholar] [CrossRef]
|
|
[9]
|
于立友, 王志栋, 吕占强, 等. 和胃化痰降浊方联合针刺治疗痰浊阻遏型高脂血症临床观察[J]. 河北中医, 2020, 42(2): 202-205, 209.
|
|
[10]
|
金俊涛, 沈红英, 沈亚莉. 调脂汤治疗混合型高脂血症痰瘀结滞证临床研究[J]. 新中医, 2020, 52(9): 49-51.
|
|
[11]
|
王馨平, 胡云华, 马儒林, 郭恒, 张景玉, 郭淑霞. 胆固醇逆转运相关基因多态性及其与环境的交互作用与血脂异常的相关性[J]. 营养学报, 2019, 41(6): 550-554, 560.
|
|
[12]
|
Palermo, F.A., Cocci, P., Mozzicafreddo, M., et al. (2015) Tri-m-Cresyl Phosphate and PPAR/LXR Interactions in Seabream Hepatocytes: Revealed by Computational Modeling (Docking) and Transcriptional Regulation of Signaling Pathways. Toxicology Research, 5, 471-481. [Google Scholar] [CrossRef]
|
|
[13]
|
Pownall, H.J., Rosales, C., Gillard, B.K. and Gotto Jr, A.M. (2021) High-Density Lipoproteins, Reverse Cholesterol Transport and Atherogenesis. Nature Reviews Cardiology, 18, 712-723. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Hevener, A.L., Olefsky, J.M., Reichart, D., et al. (2007) Macro-phage PPARγ Is Required for Normal Skeletal Muscle and Hepatic Insulin Sensitivity and Full Antidiabetic Effects of Thiazolidinediones. Journal of Clinical Investigation, 117, 1658-1669. [Google Scholar] [CrossRef]
|
|
[15]
|
Charo, I.F. (2007) Macrophage Polarization and Insulin Resistance: PPARγ in Control. Cell Metabolism, 6, 96-98. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Bai, L., Li, Z., Li, Q., et al. (2017) Mediator 1 Is Atherosclerosis Protective by Regulating Macrophage Polarization. Arteriosclerosis, Thrombosis, and Vascular Biology, 37, 1470-1481. [Google Scholar] [CrossRef]
|
|
[17]
|
Smith, J.D., Waelde, C., Horwitz, A. and Zheng, P. (2002) Evaluation of the Role of Phosphatidylserine Translocase Activity in ABCA1-Mediated Lipid Efflux. Journal of Biolog-ical Chemistry, 277, 17797-17803. [Google Scholar] [CrossRef]
|
|
[18]
|
Song, E.J., Ahn, S., Min, S.K., et al. (2021) Combined Application of Rapamycin and Atorvastatin Improves Lipid Metabolism in Apolipoprotein E-Deficient Mice with Chronic Kidney Disease. BMB Reports, 54, 170-175. [Google Scholar] [CrossRef]
|
|
[19]
|
Tsuboi, T., Lu, R., Yonezawa, T., et al. (2020) Molecular Mechanism for Nobiletin to Enhance ABCA1/G1 Expression in Mouse Macrophages. Atherosclerosis, 297, 32-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
张悦, 曾文赟, 张晓璐, 等. 中药基于ABCA1介导巨噬细胞胆固醇流出防治动脉粥样硬化的研究进展[J]. 现代中西医结合杂志, 2021, 30(26): 2960-2964.
|
|
[21]
|
Ren, K., Li, H., Zhou, H.F., et al. (2019) Mangiferin Promotes Macrophage Cholesterol Efflux and Protects against Athero-sclerosis by Augmenting the Expression of ABCA1 and ABCG1. Aging, 11, 10992-11009. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Yu, X.H., Chen, J.J., Deng, W.Y., et al. (2020) Biochanin A Mitigates Atherosclerosis by Inhibiting Lipid Accumulation and Inflammatory Response. Oxidative Medicine and Cellular Longev-ity, 2020, Article ID: 8965047. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Iio, A., Ohguchi, K., Iinuma, M., et al. (2012) Hesperetin Upregulates ABCA1 Expression and Promotes Cholesterol Efflux from THP-1 Macrophages. Journal of Natural Products, 75, 563-566. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
邱峰. 灯盏花乙素通过PPARα/γ-LXRα-ABCA1通路抗动脉粥样硬化作用机制研究[D]: [博士学位论文]. 广州: 广州中医药大学, 2018.
|
|
[25]
|
He, X.W., Yu, D., Li, W.L., et al. (2016) Anti-Atherosclerotic Potential of Baicalin Mediated by Promoting Cholesterol Efflux from Macrophages via the PPARγ-LXRα-ABCA1/ABCG1 Pathway. Biomedicine & Pharmacotherapy, 83, 257-264. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yu, R., Lv, Y., Wang, J., et al. (2016) Baicalin Promotes Cho-lesterol Efflux by Regulating the Expression of SR-BI in Macrophages. Experimental and Therapeutic Medicine, 12, 4113-4120. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Tang, H., Zeng, Q., Tang, T., Wei, Y.J. and Pu, P. (2021) Kaempferide Improves Glycolipid Metabolism Disorder by Activating PPARγ in High-Fat-Diet-Fed Mice. Life Sciences, 270, Article ID: 119133. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Wang, S., Zhang, X., Liu, M., et al. (2015) Chrysin Inhibits Foam Cell Formation through Promoting Cholesterol Efflux from RAW264.7 Macrophages. Pharmaceutical Biology, 53, 1481-1487. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Lara-Guzman, O.J., Tabares-Guevara, J.H., Leon-Varela, Y.M., et al. (2012) Proatherogenic Macrophage Activities Are Targeted by the Flavonoid Quercetin. Journal of Phar-macology and Experimental Therapeutics, 343, 296-306. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Jia, Q., Cao, H., Shen, D., et al. (2019) Quercetin Protects against Atherosclerosis by Regulating the Expression of PCSK9, CD36, PPARγ, LXRα and ABCA1. International Journal of Molecular Medicine, 44, 893-902. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Li, C.H., Gong, D., Chen, L.Y., et al. (2017) Puerarin Promotes ABCA1-Mediated Cholesterol Efflux and Decreases Cellular Lipid Accumulation in THP-1 Macrophages. European Journal of Pharmacology, 811, 74-86. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
马晶鑫, 郭金洲, 陈海宁, 谢珂, 全德森, 杜京晏, 刘林潇, 俞琦, 田维毅, 蔡琨. 淡豆豉异黄酮通过PPARγ/LXRα/ABCA1信号通路改善动脉粥样硬化小鼠脂质代谢的作用[J]. 中国实验方剂学杂志, 2022, 28(11): 110-118.
|
|
[33]
|
Dong, S.Z., Zhao, S.P., Wu, Z.H., et al. (2011) Curcumin Promotes Cholesterol Efflux from Adipocytes Related to PPARγ-LXRα-ABCA1 Passway. Molecular and Cellular Bi-ochemistry, 358, 281-285. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
李智, 高铸烨, 别玉龙, 等. 黄连素通过PPARγ-LXRα-ABCA1信号通路促进ApoE-/-小鼠胆固醇代谢的作用机制研究[J]. 中华中医药学刊, 2022, 40(10): 28-35.
|
|
[35]
|
邹瑾, 赵真旺, 吴洁, 等. 荷叶碱对巨噬细胞源性泡沫细胞ABCA1表达与胆固醇流出的影响及机制[J]. 中国动脉硬化杂志, 2018, 26(9): 872-876, 924.
|
|
[36]
|
祝骥, 滕耀红, 王萍儿, 等. 川芎嗪对泡沫细胞胆固醇逆转运的影响[J]. 中国中药杂志, 2014, 39(7): 1255-1259.
|
|
[37]
|
于宁, 宋囡, 王莹, 等. 茯苓多糖改善HDL功能并通过PPARγ/LXRα/ABCA1抗AS机制研究[J]. 中国免疫学杂志, 2021, 37(4): 389-394.
|
|
[38]
|
邵波, 李英, 王效琰, 等. 蛹虫草多糖促进CETP-tg小鼠胆固醇逆转运[J]. 中国病理生理杂志, 2020, 36(10): 1754-1760.
|
|
[39]
|
李恒. 仙人掌多糖ODP-Ia初步结构及其促进泡沫细胞胆固醇外流作用研究[D]: [博士学位论文]. 长沙: 湖南农业大学, 2017.
|
|
[40]
|
岳建美. 丹酚酸B通过PPAR-γ和LXRα途径促进巨噬细胞ABCA1依赖的胆固醇流出[D]: [博士学位论文]. 济南: 山东大学, 2015.
|
|
[41]
|
连雪科. 京尼平苷酸对人单核巨噬细胞THP-1胆固醇代谢调控机制研究[D]: [博士学位论文]. 广州: 广州中医药大学, 2018.
|
|
[42]
|
Wu, C., Luan, H., Zhang, X., et al. (2014) Chlorogenic Acid Protects against Atherosclerosis in ApoE-/- Mice and Promotes Cholesterol Efflux from RAW264.7 Macrophages. PLOS ONE, 9, e95452. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
葛樯樯, 王雪芬, 宗磊, 等. 绞股蓝总皂苷对ApoE-/-动脉粥样硬化小鼠血管PPAR-γ/LXR-α/ABCA1信号通路的影响[J]. 浙江医学教育, 2019, 18(4): 47-50.
|
|
[44]
|
李士侠. 丹参素上调LCAT和CYP7A1的表达对高血脂大鼠脂质紊乱的调节作用[J]. 现代食品科技, 2018, 34(8): 31-35, 186.
|
|
[45]
|
许笑雯. 活血化痰方调控ApoE-/-小鼠胆固醇稳态平衡及抗动脉粥样斑块形成的作用[D]: [硕士学位论文]. 上海: 上海中医药大学, 2023.
|
|
[46]
|
马星雨. 小陷胸汤对RAW264.7源泡沫细胞ABCA1/G1表达和胆固醇流出的影响[D]: [硕士学位论文]. 长沙: 湖南中医药大学, 2021.
|
|
[47]
|
徐则林, 陈新宇, 李晓屏, 等. 降脂通络方对高脂血症模型大鼠胆固醇逆转运蛋白的影响[J]. 世界中医药, 2020, 15(1): 55-58.
|
|
[48]
|
金凯祎, 杨志远, 陈少奇, 等. 复方当归提取物对高脂高糖饮酒致高脂血症大鼠的作用研究[J]. 中药新药与临床药理, 2019, 30(4): 416-422.
|
|
[49]
|
刘小转. 黄连温胆汤对2型糖尿病合并脂质代谢紊乱患者LCAT、EL的影响[D]: [硕士学位论文]. 合肥: 安徽中医药大学, 2019.
|
|
[50]
|
陈玉兴, 李茹月, 黄雪君, 等. 布芍调脂胶囊对高脂血症大鼠脂质代谢的影响及其作用靶点研究[J]. 临床医学工程, 2017, 24(11): 1525-1527.
|
|
[51]
|
王华, 何雄. 护心通络方通过干预CETP介导脂质代谢抗兔动脉粥样硬化的实验研究[J]. 天津医药, 2022, 50(8): 827-831.
|
|
[52]
|
周盼盼. 四味余甘子方对高脂血症模型大鼠干预作用的研究[D]: [硕士学位论文]. 西宁: 青海大学, 2021.
|
|
[53]
|
张龚庆, 杨如意. 四味余甘子方对高脂血症大鼠肝脏SREBP-1c及FAS的干预作用[J]. 中华中医药杂志, 2022, 37(3): 1698-1703.
|
|
[54]
|
陈丝, 宋囡, 崔馨月, 等. 香砂六君子汤对脾虚高脂血症模型大鼠胆固醇逆向转运的影响[J]. 中医杂志, 2019, 60(17): 1493-1498.
|
|
[55]
|
戴瑜娉. 熊氏十味温胆汤对泡沫细胞胆固醇逆转运的干预初探[D]: [硕士学位论文]. 长沙: 湖南中医药大学, 2022.
|
|
[56]
|
何小丽, 顾宁. 宁心痛颗粒含药血清及有效组分干预THP-1源性巨噬细胞泡沫化的效应与机制[J]. 中国中西医结合杂志, 2017, 37(11): 1339-1344.
|
|
[57]
|
李晓辉, 李洪禹, 成光宇, 等. 散结通脉方对脂质代谢相关蛋白表达及动脉粥样硬化的影响[J]. 吉林中医药, 2023, 43(2): 205-210.
|
|
[58]
|
许二巾. 当归补血汤抗ApoE基因敲除小鼠动脉粥样硬化的作用及机制的研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2019.
|
|
[59]
|
杜莹, 贾连群, 宋囡, 等. 化瘀祛痰方对高脂血症大鼠sd-LDL的影响及机制研究[J]. 中华中医药学刊, 2019, 37(8): 1935-1939.
|
|
[60]
|
谢凯枫, 卓俊城, 曾晓会, 等. 银蓝调脂胶囊通过促进RCT和TG水解调控高脂血症小鼠脂质代谢的机制研究[J]. 中药材, 2018, 41(4): 955-960.
|
|
[61]
|
杜海霞, 周惠芬, 何昱, 等. 基于脂质代谢紊乱探讨丹红注射液对高脂血症大鼠的降脂作用及机制[J]. 中国中药杂志, 2020, 45(13): 3203-3210.
|
|
[62]
|
陈玄晶, 吴炳鑫, 吴焕林, 等. 温胆汤通过调节胆固醇逆转运相关膜蛋白表达抑制ApoE-/-小鼠动脉粥样硬化斑块形成[J]. 中国病理生理杂志, 2020, 36(12): 2123-2132.
|
|
[63]
|
于露, 鲁海菲, 李若绮, 等. 双蓣调脂汤对高胆固醇血症大鼠肝组织SRB1/CYP7A1/FXR信号通路的影响[J]. 中国实验方剂学杂志, 2021, 27(3): 47-55.
|
|
[64]
|
蒲施臣. 青蒿琥酯通过AMPK、PPAR信号通路对脂质代谢影响机制的研究[D]: [硕士学位论文]. 上海: 上海交通大学, 2020.
|
|
[65]
|
罗朵生, 孙玲, 陈可纯, 等. 田黄方抑制ApoE-/-小鼠动脉粥样硬化作用及机制研究[J]. 中国中西医结合杂志, 2019, 39(4): 465-469.
|
|
[66]
|
梅俊, 周庆兵, 徐凤芹. 芎芍胶囊含药血清对RAW264.7源性泡沫细胞胆固醇流出的影响[J]. 中国中西医结合杂志, 2020, 40(1): 65-69.
|
|
[67]
|
吴希泽, 康健, 李越, 等. 基于“浊气归心, 淫精于脉”理论运用HPLC-Q-TOF-MS/MS和网络药理学探讨抵挡汤防治动脉粥样硬化和高脂血症的作用机制[J]. 中国中药杂志, 2023, 48(5): 1352-1369.
|